Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

New scaffolds encapsulating TGF-β3/BMP-7 combinations driving strong chondrogenic differentiation.

Crecente-Campo J, Borrajo E, Vidal A, Garcia-Fuentes M.

Eur J Pharm Biopharm. 2017 May;114:69-78. doi: 10.1016/j.ejpb.2016.12.021. Epub 2017 Jan 10.

PMID:
28087378
2.

Biomaterials to suppress cancer stem cells and disrupt their tumoral niche.

Garcia-Mazas C, Csaba N, Garcia-Fuentes M.

Int J Pharm. 2017 May 25;523(2):490-505. doi: 10.1016/j.ijpharm.2016.12.013. Epub 2016 Dec 8.

PMID:
27940172
3.

Polyarginine Nanocapsules as a Potential Oral Peptide Delivery Carrier.

Lollo G, Gonzalez-Paredes A, Garcia-Fuentes M, Calvo P, Torres D, Alonso MJ.

J Pharm Sci. 2017 Feb;106(2):611-618. doi: 10.1016/j.xphs.2016.09.029. Epub 2016 Nov 14.

PMID:
27855960
4.

Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer.

Borrajo E, Abellan-Pose R, Soto A, Garcia-Fuentes M, Csaba N, Alonso MJ, Vidal A.

J Control Release. 2016 Sep 28;238:263-271. doi: 10.1016/j.jconrel.2016.07.048. Epub 2016 Jul 29.

PMID:
27476608
5.

Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size.

Abellan-Pose R, Teijeiro-Valiño C, Santander-Ortega MJ, Borrajo E, Vidal A, Garcia-Fuentes M, Csaba N, Alonso MJ.

Int J Pharm. 2016 Jul 25;509(1-2):107-117. doi: 10.1016/j.ijpharm.2016.05.034. Epub 2016 May 19.

PMID:
27210735
6.

Pore size is a critical parameter for obtaining sustained protein release from electrochemically synthesized mesoporous silicon microparticles.

Pastor EL, Reguera-Nuñez E, Matveeva E, Garcia-Fuentes M.

PeerJ. 2015 Oct 6;3:e1277. doi: 10.7717/peerj.1277. eCollection 2015.

7.

Television viewing time and risk of eating disorders in Spanish adolescents: AVENA and AFINOS studies.

Martínez-Gómez D, Veses AM, Gómez-Martínez S, Pérez de Heredia F, Castillo R, Santaliestra-Pasias AM, Calle ME, Garcia-Fuentes M, Veiga OL, Marcos A.

Pediatr Int. 2015 Jun;57(3):455-60. doi: 10.1111/ped.12662.

PMID:
25907599
8.

Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma.

González-Gómez P, Crecente-Campo J, Zahonero C, de la Fuente M, Hernández-Laín A, Mira H, Sánchez-Gómez P, Garcia-Fuentes M.

Oncotarget. 2015 May 10;6(13):10950-63.

9.

Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative.

Lollo G, Hervella P, Calvo P, Avilés P, Guillén MJ, Garcia-Fuentes M, Alonso MJ, Torres D.

Int J Pharm. 2015 Apr 10;483(1-2):212-9. doi: 10.1016/j.ijpharm.2015.02.028. Epub 2015 Feb 11.

PMID:
25681727
10.

Cognition and the risk of eating disorders in Spanish adolescents: the AVENA and AFINOS studies.

Veses AM, Gómez-Martínez S, de Heredia FP, Esteban-Cornejo I, Castillo R, Estecha S, García-Fuentes M, Veiga OL, Calle ME, Marcos A.

Eur J Pediatr. 2015 Feb;174(2):229-36. doi: 10.1007/s00431-014-2386-3. Epub 2014 Jul 31.

PMID:
25074843
11.

Nanocarriers & drug delivery: rational design and applications.

Garcia-Fuentes M, Gonzalez-Díaz H, Csaba N.

Curr Top Med Chem. 2014;14(9):1095-6. No abstract available.

PMID:
24678712
12.

PEGylated lipid nanocapsules with improved drug encapsulation and controlled release properties.

Hervella P, Alonso-Sande M, Ledo F, Lucero ML, Alonso MJ, Garcia-Fuentes M.

Curr Top Med Chem. 2014;14(9):1115-23.

PMID:
24678710
13.

Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel.

Lollo G, Rivera-Rodriguez GR, Bejaud J, Montier T, Passirani C, Benoit JP, García-Fuentes M, Alonso MJ, Torres D.

Eur J Pharm Biopharm. 2014 May;87(1):47-54. doi: 10.1016/j.ejpb.2014.02.004. Epub 2014 Feb 11.

PMID:
24530693
14.

Implantable controlled release devices for BMP-7 delivery and suppression of glioblastoma initiating cells.

Reguera-Nuñez E, Roca C, Hardy E, de la Fuente M, Csaba N, Garcia-Fuentes M.

Biomaterials. 2014 Mar;35(9):2859-67. doi: 10.1016/j.biomaterials.2013.12.001. Epub 2014 Jan 7.

PMID:
24406213
15.

A new potential nano-oncological therapy based on polyamino acid nanocapsules.

Gonzalo T, Lollo G, Garcia-Fuentes M, Torres D, Correa J, Riguera R, Fernandez-Megia E, Calvo P, Avilés P, Guillén MJ, Alonso MJ.

J Control Release. 2013 Jul 10;169(1-2):10-6.

PMID:
23591661
16.

Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles.

Trapani A, Di Gioia S, Ditaranto N, Cioffi N, Goycoolea FM, Carbone A, Garcia-Fuentes M, Conese M, Alonso MJ.

Int J Pharm. 2013 Apr 15;447(1-2):115-23. doi: 10.1016/j.ijpharm.2013.02.035. Epub 2013 Feb 20.

PMID:
23454518
17.

Nutrition and physical activity programs for obesity treatment (PRONAF study): methodological approach of the project.

Zapico AG, Benito PJ, González-Gross M, Peinado AB, Morencos E, Romero B, Rojo-Tirado MA, Cupeiro R, Szendrei B, Butragueño J, Bermejo M, Alvarez-Sánchez M, García-Fuentes M, Gómez-Candela C, Bermejo LM, Fernandez-Fernandez C, Calderón FJ.

BMC Public Health. 2012 Dec 21;12:1100. doi: 10.1186/1471-2458-12-1100.

18.

Five year trends on total and abdominal adiposity in Spanish adolescents.

Moreno LA, Moliner-Urdiales D, Ruiz JR, Mesana MI, Vicente-Rodríguez G, Rodríguez G, Fleta J, León JF, García-Fuentes M, Castillo MJ, González-Gross M, Marcos A; AVENA study group; HELENA study group.

Nutr Hosp. 2012 May-Jun;27(3):731-8. doi: 10.3305/nh.2012.27.3.5726.

19.

Chitosan-based drug nanocarriers: where do we stand?

Garcia-Fuentes M, Alonso MJ.

J Control Release. 2012 Jul 20;161(2):496-504. doi: 10.1016/j.jconrel.2012.03.017. Epub 2012 Mar 23. Review.

PMID:
22480607
20.

Protein delivery based on uncoated and chitosan-coated mesoporous silicon microparticles.

Pastor E, Matveeva E, Valle-Gallego A, Goycoolea FM, Garcia-Fuentes M.

Colloids Surf B Biointerfaces. 2011 Dec 1;88(2):601-9. doi: 10.1016/j.colsurfb.2011.07.049. Epub 2011 Jul 30.

PMID:
21855304

Supplemental Content

Loading ...
Support Center